Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-020758
Filing Date
2020-03-23
Accepted
2020-03-23 19:40:53
Documents
1
Period of Report
2020-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1579
  Complete submission text file 0001209191-20-020758.txt   3111
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BOULEVARD, SUITE 2150 LOS ANGELES CA 90024
Business Address
Ludwig Jeffrey Jerome (Reporting) CIK: 0001807133 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35703 | Film No.: 20736267